NASDAQ · AYTU
Aytu BioPharma, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for AYTU: Nov 12, 2026
Aytu BioPharma, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.1. The reported EPS for the same quarter last year was $-0.08.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Dec 2026 | $-0.09 | $-0.09 | $-0.09 | 1 |
| Mar 2027 | $-0.04 | $-0.04 | $-0.04 | 1 |
| Jun 2027 | $0.06 | $0.06 | $0.06 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool- Zacks · Oct 7, 11:08 AM EDTElite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?ELTP and AYTU have different CNS portfolios, growth drivers and valuations, but which pharmaceutical stock looks better positioned? Let's dive in.
- Zacks · Sep 22, 5:15 PM EDTAytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue EstimatesAytu BioPharma, Inc. (AYTU) delivered earnings and revenue surprises of +77.27% and +39.45%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Sep 14, 5:35 PM EDTHeartSciences Inc. (HSCS) Reports Q1 Loss, Misses Revenue EstimatesHeartSciences Inc. (HSCS) delivered earnings and revenue surprises of -10.26% and -97.90%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 20, 6:31 AM EDTNew Strong Sell Stocks for July 20thACR, AEM and AYTU have been added to the Zacks Rank #5 (Strong Sell) List on July 20, 2026.
- Zacks · Jul 16, 4:32 AM EDTNew Strong Sell Stocks for July 16thAYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.
- The Motley Fool · May 13, 5:54 PM EDTAytu (AYTU) Q3 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 13, 5:35 PM EDTAytu BioPharma, Inc. (AYTU) Reports Q3 Loss, Tops Revenue EstimatesAytu BioPharma, Inc. (AYTU) delivered earnings and revenue surprises of -70.97% and +3.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 12, 8:25 AM EDTImmatics (IMTX) Reports Q1 Loss, Lags Revenue EstimatesImmatics (IMTX) delivered earnings and revenue surprises of -19.05% and -38.95%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 7:05 PM EDTPuma Biotech (PBYI) Reports Q1 Loss, Tops Revenue EstimatesPuma Biotech (PBYI) delivered earnings and revenue surprises of +68.00% and +14.23%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Feb 3, 6:15 PM ESTAytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue EstimatesAytu BioPharma (AYTU) delivered earnings and revenue surprises of -303.85% and +26.27%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
- The Motley Fool · Feb 3, 5:37 PM ESTAytu BioPharma AYTU Q2 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Feb 2, 5:37 AM ESTNew Strong Sell Stocks for February 2ndAAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Aytu BioPharma, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.